Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets

Michael T Fisher1, Mitzi Nagarkatti, Prakash S Nagarkatti

  • 1Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23113, USA.

Insights

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure upregulates genes involved in T cell selection in the thymus. This suggests TCDD may cause thymic atrophy by enhancing T cell negative selection.

Area of Science:

  • Immunology
  • Toxicology
  • Molecular Biology

Background:

  • 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent environmental toxicant.
  • The thymus is a primary organ for T cell development and immune tolerance.
  • Mechanisms underlying TCDD-induced thymic toxicity are not fully understood.

Purpose of the Study:

  • Identify novel genes mediating TCDD toxicity in the thymus.
  • Investigate the role of TCDD in regulating genes involved in T cell selection.
  • Elucidate the molecular pathways affected by TCDD exposure in thymocytes.

Main Methods:

  • Pathway-specific cDNA arrays for gene expression profiling.
  • Analysis of gene promoter regions for dioxin-responsive elements (DREs).
  • Chromatin immunoprecipitation to confirm aryl hydrocarbon receptor (AhR) binding.

Main Results:

  • TCDD exposure upregulated several TNF and TNFR family members, including Fas, LIGHT, CD30, OX40, and TNF-alpha.
  • Pro-apoptotic (Bax, Hrk) and pro-survival (Bcl-x, Bcl-w) bcl-2 family genes were induced.
  • Fas and LIGHT gene promoters contained DREs, with confirmed AhR binding.
  • Upregulation of Fas, LIGHT, and CD30 suggests enhanced T cell negative selection.

Conclusions:

  • TCDD exposure induces genes critical for T cell negative selection in the thymus.
  • AhR binding to DREs in Fas and LIGHT promoters mediates TCDD's effects.
  • Enhanced negative selection likely contributes to TCDD-induced thymic atrophy.